Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind multicenter skin test comparison of native, depigmented, and depigmented-polymerized peanut allergen extracts
2010-019355-22Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Jun 2010
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, double-blind trial of DBV712 Viaskin® in peanut allergy, sponsored by LETI Pharma. Started Jun 2010; status: completed.
02
Drugs
DBV712 Viaskin®
03
Conditions
peanut allergy
Beyond the preview
Go deeper on 2010-019355-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019355-22.